Abstract:Abstract Familial Mediterranean fever (FMF) is an autosomal recessive autoinflammatory disease characterized by recurring serosal inflammation. Cardiac involvement in FMF commonly manifests as pericarditis and pericardial effusion; however, there is limited research on myocardial function. This study aimed to assess cardiac functions during active inflammation and remission periods of FMF patients and investigate the cardiac effects of inflammation during the attack period. Thirty-eight FMF patients without additional cardiac diseases were included in the study. Demographic characteristics, clinical symptoms, family history, and MEFV gene analysis results were obtained retrospectively. Blood tests, blood pressure measurements, electrocardiogram evaluations, conventional echocardiography, and speckle tracking echocardiography were performed during the attack and remission periods. Disease severity was assessed using the Pras scoring system. During the attack period, FMF patients exhibited significantly higher leukocyte count, neutrophil count, C-reactive protein, and erythrocyte sedimentation rate compared to the remission period ( p < 0.005). Speckle tracking echocardiography revealed decreased function in the inferior segments of the left ventricle during the attack period ( p < 0.005). Right ventricular function was more affected in the moderate disease group. FMF patients with lymphopenia during the attack demonstrated more impaired right ventricular function compared to those with normal lymphocyte count. Conclusions : FMF patients experience cardiac abnormalities during active inflammation, highlighting the importance of monitoring cardiac functions in these patients. Speckle tracking echocardiography can provide valuable insights into cardiac involvement in FMF. These findings emphasize the cardiac impact of FMF inflammation and the significance of long-term cardiac function monitoring in the management of FMF patients. What is Known: • The current literature lacks studies investigating myocardial function in the pediatric population during the attack period of this particular disease. • Our objective was to assess the alterations in cardiac function during the attack and remission periods, considering clinical manifestations, disease severity, acute phase reactant levels, and mutation type. We also evaluated the pattern of cardiac involvement and the affected cardiac areas by comparing remission and attack periods . What is New: • Several studies have demonstrated a rise in the prevalence of ischemic cardiac disease and mortality among individuals with FMF. • Investigating cardiac involvement during the attack period in FMF patients can provide valuable insights for the prevention of long-term complications.

Small bowel mucosal damage in familial Mediterranean fever: results of capsule endoscopy screening

Familial Mediterranean fever with colonic lesions: A case report

Colitis in a patient with familial Mediterranean fever: Is it Crohn's disease or ulcerative colitis?

Potential association between M694V homozygous mutation in familial Mediterranean fever and eosinophilic intestinal inflammation: a pediatric case series

A Case of Atypical Familial Mediterranean Fever With Pseudopolyposis-Like Mucosal Changes in the Ileum

Examination of cardiac functions during acute attack and remission period in children with familial Mediterranean fever

Exploring S100A8/A9, neopterin, and MMP3 in familial Mediterranean fever

Unraveling the genome: Familial Mediterranean fever

Evaluation of cardiac functions in children with familial Mediterranean fever

The journey of MEFV heterozygous children: with or without colchicine

Assessment of epicardial adipose tissue thickness and the mean platelet volume in children with familial Mediterranean fever

Characteristics of arthritis in patients with familial Mediterranean fever

Histamine elevation in familial Mediterranean fever: A study from the Juvenile Inflammatory Rheumatism cohort

Molecular investigation of MEFV gene polymorphisms among patients with familial mediterranean fever-like symptoms

Canakinumab treatment in children with familial Mediterranean fever: report from a single center

Familial Mediterranean fever in Armenian children with inflammatory bowel disease

Retrospective evaluation of obstetric processes in patients with Familial Mediterranean Fever's disease: The three years experience of a tertiary rheumatology clinic

Ocular blood flow and retinal, choroidal, and retinal nerve fiber layer thickness in children with familial Mediterranean fever with at least five attacks

Subclinical enthesitis in enthesitis-related arthritis and sacroiliitis associated with familial Mediterranean fever

Mucosal Genes Expression in Inflammatory Bowel Disease Patients: New Insights

Elevated fecal calprotectin and lactoferrin associated with small intestinal lesions in patients with Behçet disease